[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fBTuJhe-nAL8lKjiuAuu2ROOG0h2ECnulwaT3IXDgVNo":8,"$fn7I8ePVyehlDglpsckYkWUQBUTLf2ULSZeUq8XfGmLE":55,"$fpUUmRT5sHAJkgQ0VKBtMoSpZ9whGr9XcJ6a-0GMrI-8":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},48755,867568,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//Qwz6GyCWTi4XHRajDQhvP0c86fSiOy65.png","李文旭","温州老年病医院","肿瘤科","主治医师",317,0,"胃癌治疗新选择：FOLFOX化疗与信迪利单抗的用药要点全解","","https://ystcdn.venuertc.com/venue/AI/e3ed7787-0487-429d-b71e-451d915f3daf.jpg","\u003Cdiv class=\"med_guide-container\">\n  \u003Ch2 id=\"material_title\" class=\"med_guide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">胃癌治疗新选择：FOLFOX化疗与信迪利单抗的用药要点全解\u003C/h2>\n  \n  \u003Cdiv class=\"med_guide-section med_guide-section-bg1\">\n    \u003Ch2 class=\"med_guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">FOLFOX与信迪利单抗：两类药品，作用不同\u003C/h2>\n    \u003Cdiv class=\"med_guide-content\">\n      \u003Cp>\n        说到胃部肿瘤的治疗，FOLFOX化疗方案和信迪利单抗这两类药品常常一起出现。前者属于细胞毒性化疗药的组合，后者则是免疫检查点抑制剂。虽然都是静脉给药，但具体药理机制与使用方式各有侧重。下文将带领大家一次性掌握这两类药物的成分特点、作用机制、常用方法、相互作用，不良反应，以及存储与特殊人群用药等实用细节，让安全合理用药不再难。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"med_guide-section med_guide-section-bg2\">\n    \u003Ch2 class=\"med_guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">FOLFOX化疗方案：成分与作用机制🧪\u003C/h2>\n    \u003Cdiv class=\"med_guide-content\">\n      \u003Cul>\n        \u003Cli>\u003Cb>核心成分\u003C/b>：常用组合包括奥沙利铂（Oxaliplatin）、亚叶酸钙（Leucovorin, 又称亚叶酸）、氟尿嘧啶（5-Fluorouracil, 5-FU）。\u003C/li>\n        \u003Cli>\u003Cb>剂型与规格\u003C/b>：全部为注射剂，需在医疗机构静脉输注。\u003C/li>\n        \u003Cli>\u003Cb>机制简述\u003C/b>：\n          \u003Cul>\n            \u003Cli>奥沙利铂：通过与DNA结合，阻止细胞分裂。\u003C/li>\n            \u003Cli>5-氟尿嘧啶：抑制DNA和RNA合成。\u003C/li>\n            \u003Cli>亚叶酸钙：增强5-FU的抗肿瘤效果。\u003C/li>\n          \u003C/ul>\n          这种“组合拳”提高了治疗的协同效应。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"med_guide-section med_guide-section-bg3\">\n    \u003Ch2 class=\"med_guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">信迪利单抗：免疫调节新手段🧬\u003C/h2>\n    \u003Cdiv class=\"med_guide-content\">\n      \u003Cul>\n        \u003Cli>\u003Cb>成分及剂型\u003C/b>：重组人源化抗PD-1单克隆抗体，按规定规格配制为注射剂。\u003C/li>\n        \u003Cli>\u003Cb>作用机制\u003C/b>：通过阻断PD-1通路，解除肿瘤对机体免疫的“刹车”，使免疫系统能识别并杀伤异常细胞。\u003C/li>\n        \u003Cli>\u003Cb>使用方式\u003C/b>：通常静脉滴注，输注时间一般不少于30分钟。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"med_guide-section med_guide-section-bg4\">\n    \u003Ch2 class=\"med_guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">FOLFOX方案用法用量🔬\u003C/h2>\n    \u003Cdiv class=\"med_guide-content\">\n      \u003Cul>\n        \u003Cli>\u003Cb>常用流程\u003C/b>\u003Cbr>\n         一疗程包括：\n          \u003Cul>\n            \u003Cli>奥沙利铂于第1天静脉滴注（通常2小时）\u003C/li>\n            \u003Cli>亚叶酸钙和5-FU同日或分时序贯静脉给药，5-FU有短时推注+持续输注两种给法。\u003C/li>\n            \u003Cli>大多数疗程每2周重复一次；具体剂量按体表面积或体重精确计算。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\u003Cb>补充说明\u003C/b>：化疗需严格由有经验的医师评估后制定方案，不宜自行调整。\u003C/li>\n        \u003Cli>\u003Cb>有位72岁男性患者\u003C/b>在专业医生指导下接受了11周期的FOLFOX方案化疗，过程平稳。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"med_guide-section med_guide-section-bg5\">\n    \u003Ch2 class=\"med_guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">信迪利单抗：正确用法和给药细节🩺\u003C/h2>\n    \u003Cdiv class=\"med_guide-content\">\n      \u003Cul>\n        \u003Cli>\u003Cb>推荐方法\u003C/b>：按体重计量，常用剂量为每次200mg静脉滴注，每3周或每2周一次。\u003C/li>\n        \u003Cli>\u003Cb>输注要求\u003C/b>：药液需用0.9%氯化钠稀释到合适体积，输注时间不低于30分钟，整个过程需严密监护。\u003C/li>\n        \u003Cli>\u003Cb>特殊提醒\u003C/b>：调整剂量或停药通常依据患者的个体反应及不良反应，切勿自行更改。\u003C/li>\n        \u003Cli>\u003Cb>临床中\u003C/b>，有患者在接受信迪利单抗联用FOLFOX方案期间，需定期监测各项血液参数。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"med_guide-section med_guide-section-bg6\">\n    \u003Ch2 class=\"med_guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">药物相互作用：需要注意哪些组合🤝\u003C/h2>\n    \u003Cdiv class=\"med_guide-content\">\n      \u003Cul>\n        \u003Cli>FOLFOX方案内药物本身无严重拮抗，但与以下药品有相互作用风险：\n          \u003Cul>\n            \u003Cli>部分抗生素（如甲硝唑）与奥沙利铂同时使用可能加剧神经毒性反应。\u003C/li>\n            \u003Cli>5-FU与间接抗病毒药、异烟肼等合并时须谨慎，影响药效或毒副反应。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>信迪利单抗与强效免疫抑制剂合用可能降低药效，因此双方通常需权衡利弊。\u003C/li>\n        \u003Cli>\u003Cb>正确做法：\u003C/b> 如需联用其他药物，务必提前与医生、药师沟通，勿私自添加新药。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"med_guide-section med_guide-section-bg7\">\n    \u003Ch2 class=\"med_guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">常见不良反应及处理方法💡\u003C/h2>\n    \u003Cdiv class=\"med_guide-content\">\n      \u003Cul>\n        \u003Cli>\u003Cb>FOLFOX方案\u003C/b>\n          \u003Cul>\n            \u003Cli>最常见的是骨髓抑制（白细胞和血小板减少）：需定期检查血象，严重时可暂停或调整剂量。\u003C/li>\n            \u003Cli>奥沙利铂可引起周围神经麻木，部分患者出现手脚刺痛，低温加重。\u003C/li>\n            \u003Cli>部分人会有恶心、呕吐，应用止吐药进行防护。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\u003Cb>信迪利单抗\u003C/b>\n          \u003Cul>\n            \u003Cli>可能出现疲劳、皮疹、皮肤瘙痒。\u003C/li>\n            \u003Cli>少数表现为免疫相关性副作用，包括内分泌功能变动等，需及时处理。\u003C/li>\n            \u003Cli>输注期间偶有过敏反应，一旦出现呼吸困难等症状，应立即停止输注并进行处理。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\u003Cb>数据表明\u003C/b>，FOLFOX联合免疫治疗的耐受性较好，但每个人反应不同，不适症状请及时告知医生。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"med_guide-section med_guide-section-bg1\">\n    \u003Ch2 class=\"med_guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">特殊人群用药策略👨‍👩‍👧‍👦\u003C/h2>\n    \u003Cdiv class=\"med_guide-content\">\n      \u003Cul>\n        \u003Cli>\u003Cb>老年人\u003C/b>：器官储备功能降低，剂量调整应更为谨慎；用药前需全面评估肝、肾等重要脏器功能。\u003C/li>\n        \u003Cli>\u003Cb>肝肾功能异常\u003C/b>：\n          \u003Cul>\n            \u003Cli>FOLFOX方案因奥沙利铂和5-FU经肝肾代谢，功能受损时须减量。\u003C/li>\n            \u003Cli>信迪利单抗目前尚缺乏针对严重肝肾损伤的足够数据，需权衡使用。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\u003Cb>孕妇及哺乳期女性\u003C/b>：尚未证实用药安全性，建议避免。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"med_guide-section med_guide-section-bg2\">\n    \u003Ch2 class=\"med_guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">储存要求与有效期标注📦\u003C/h2>\n    \u003Cdiv class=\"med_guide-content\">\n      \u003Cul>\n        \u003Cli>FOLFOX各成分原液：\n          \u003Cul>\n            \u003Cli>密封避光保存，置于2~8°C冰箱（不得冷冻）。\u003C/li>\n            \u003Cli>配制后溶液应尽快用完，最长不得超过24小时。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>信迪利单抗注射液：\n          \u003Cul>\n            \u003Cli>未启封时为2～8°C，开瓶须立即用完。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\u003Cb>正确做法：\u003C/b> 切勿将化疗药物随意放在家庭普通冰箱或暴露于高温环境，避免儿童接触。\u003C/li>\n        \u003Cli>过期或未用完的药液要按医疗垃圾专规处理。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"med_guide-section med_guide-section-bg3\">\n    \u003Ch2 class=\"med_guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">漏服与过量处理办法⏰\u003C/h2>\n    \u003Cdiv class=\"med_guide-content\">\n      \u003Cul>\n        \u003Cli>FOLFOX和信迪利单抗均为医疗机构静脉输液操作，一般无“漏服”情况。如中断一次治疗，应尽快重新预约，由医生判断处理方案。\u003C/li>\n        \u003Cli>一旦过量给药，需密切生命体征和实验室指标监测，严重者住院处理。\u003C/li>\n        \u003Cli>\u003Cb>建议：\u003C/b>无需自行补充，用药问题出现时第一时间联络主治医师。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"med_guide-section med_guide-section-bg4\">\n    \u003Ch2 class=\"med_guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">用药案例分享🗂️\u003C/h2>\n    \u003Cdiv class=\"med_guide-content\">\n      \u003Cul>\n        \u003Cli>一名72岁男性，在医生指导下接受了11个周期的FOLFOX化疗联合免疫治疗，全程密切检测血象和肝肾功能，未见明显异常，各项指标保持平稳。\u003C/li>\n        \u003Cli>临床中遇到部分患者联合治疗时出现轻微皮疹，通过短期停药处理后再恢复，仅极少数需要永久停药或转换方案。\u003C/li>\n        \u003Cli>联合治疗时曾有患者因偶发血小板下降调整了药物剂量，后期多次复查都能稳定在安全范围内。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"med_guide-section med_guide-section-bg5\">\n    \u003Ch2 class=\"med_guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">用药总结与关键提醒📝\u003C/h2>\n    \u003Cdiv class=\"med_guide-content\">\n      \u003Cul>\n        \u003Cli>FOLFOX化疗与信迪利单抗免疫治疗联合运用，为胃部肿瘤患者带来了新的选择，但安全性依赖于规范的操作与监测。\u003C/li>\n        \u003Cli>重点把握静脉给药流程、药物配伍禁忌、不良反应识别、特殊人群剂量调整、储存条件，以及出现药物相关问题及时报告。\u003C/li>\n        \u003Cli>正确用药，不仅能提高治疗效果，也能避免风险。如果对用药过程、合并用药或不良反应有疑问，优先联系专业医生与药师。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"med_guide-section med_guide-section-ref\">\n    \u003Ch2 class=\"med_guide-ref-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h2>\n    \u003Col>\n      \u003Cli>Cunningham, D., Allum, W. H., Stenning, S. P., Thompson, J. N., Van de Velde, C. J., Nicolson, M., ... & Scarffe, J. H. (2006). Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. \u003Ci>New England Journal of Medicine\u003C/i>, 355(1), 11-20.\u003C/li>\n      \u003Cli>Hato, T., Goyal, L., & Greten, T. F. (2014). Immune checkpoint blockade in gastrointestinal cancers. \u003Ci>Journal of Hematology & Oncology\u003C/i>, 7(1), 1-12.\u003C/li>\n      \u003Cli>Li, X., Weng, H., Xu, C., Wang, F., & Wang, X. (2020). Safety and efficacy of PD-1 / PD-L1 inhibitors in combination with chemotherapy for the first-line treatment of advanced gastric cancer. \u003Ci>Frontiers in Oncology\u003C/i>, 10, 324.\u003C/li>\n      \u003Cli>de Weger, V. A., Turksma, A. W., ten Hacken, N. H. T., et al. (2017). Safety and Pharmacokinetics of Oxaliplatin With Leucovorin and 5- Fluorouracil (FOLFOX): A Review. \u003Ci>Clinical Colorectal Cancer\u003C/i>, 16(4), 334-344.\u003C/li>\n    \u003C/ol>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.med_guide-container {\n  background: #f8fafc;\n  max-width: 780px;\n  margin: 40px auto;\n  font-family: \"Helvetica Neue\", Arial, \"PingFang SC\", \"Microsoft YaHei\", sans-serif;\n  color: #223344;\n  padding: 32px 26px 16px 26px;\n  border-radius: 16px;\n  box-shadow: 0 4px 20px rgba(120,120,120,0.07);\n  box-sizing: border-box;\n  font-size: 17px;\n  line-height: 1.7;\n}\n.med_guide-title {\n  text-align: center;\n  font-size: 2.4em;\n  font-weight: bold;\n  color: #2d476e;\n  margin-bottom: 38px;\n  position: relative;\n  letter-spacing: 1.2px;\n}\n.med_guide-section {\n  margin-bottom: 44px;\n  border-radius: 13px;\n  padding-bottom: 1px;\n}\n.med_guide-subtitle {\n  font-size: 1.34em;\n  background: linear-gradient(50deg,#e4ecf8 65%,#e4f2ed 100%);\n  color: #205a82;\n  border-radius: 13px 13px 0 0;\n  margin: 0;\n  padding: 22px 0 15px 28px;\n  border-left: 9px solid #8dc9f1;\n  font-weight: 600;\n  box-shadow: 0 2px 12px rgba(160,180,220,0.07);\n  letter-spacing: 0.6px;\n  position: relative;\n}\n.med_guide-content {\n  background: #ffffff;\n  border-radius: 0 0 13px 13px;\n  padding: 20px 30px 18px 30px;\n  margin-top: 0;\n}\n.med_guide-content ul {\n  margin: 0 0 0 12px;\n  padding-left: 18px;\n}\n.med_guide-content ul li {\n  margin-top: 0.45em;\n  margin-bottom: 0.45em;\n}\n.med_guide-content ul ul {\n  padding-left: 17px;\n  margin-top: 0.28em;\n  margin-bottom: 0.18em;\n}\n.med_guide-section-bg1 .med_guide-subtitle {\n  background: linear-gradient(80deg,#e9f2fc 70%, #e4f7e6 100%);\n  border-left-color: #a5c5ef;\n}\n.med_guide-section-bg2 .med_guide-subtitle {\n  background: linear-gradient(50deg,#e9f7fd 65%,#ebf4e7 100%);\n  border-left-color: #78bbe4;\n}\n.med_guide-section-bg3 .med_guide-subtitle {\n  background: linear-gradient(30deg,#e3f0f8 60%,#e5f5f6 100%);\n  border-left-color: #c0e2cf;\n}\n.med_guide-section-bg4 .med_guide-subtitle {\n  background: linear-gradient(70deg,#eef8ea 70%,#eefafb 100%);\n  border-left-color: #9dc99f;\n}\n.med_guide-section-bg5 .med_guide-subtitle {\n  background: linear-gradient(60deg,#f0f9fa 65%,#f5fbee 100%);\n  border-left-color: #b5e9ee;\n}\n.med_guide-section-bg6 .med_guide-subtitle {\n  background: linear-gradient(60deg,#edf5f7 65%,#fafbdd 100%);\n  border-left-color: #e7e6a5;\n}\n.med_guide-section-bg7 .med_guide-subtitle {\n  background: linear-gradient(60deg,#f9f3e6 65%,#fafbdd 100%);\n  border-left-color: #e5c89e;\n}\n.med_guide-section-ref {\n  padding-top: 16px;\n  margin-top: 40px;\n}\n.med_guide-ref-title {\n  color: #375e8e;\n  font-weight: bold;\n  font-size: 1.14em;\n  margin-left: 4px;\n}\n.med_guide-section-ref ol {\n  padding: 0 18px;\n  margin: 0;\n}\n.med_guide-section-ref li {\n  padding: 3px 0;\n  margin-bottom: 2px;\n  font-size:1em;\n}\n@media (max-width: 750px) {\n  .med_guide-container {\n    padding: 9px 3vw 4vw 3vw;\n    font-size: 15px;\n  }\n  .med_guide-content {\n    padding: 14px 8px 13px 10px;\n  }\n  .med_guide-title {\n    font-size: 1.45em;\n    padding-left: 2px;\n    padding-right: 2px;\n  }\n  .med_guide-subtitle {\n    font-size: 1.08em;\n    padding-left:10px;\n  }\n}\n\u003C/style>\n","\u003Cdiv class=\"med_guide-container\">\n  \u003Ch2 id=\"material_title\" class=\"med_guide-title\" style=\"color: rg",522,"2025-07-14 15:28:42","FOLFOX化疗, 胃癌, 信迪利单抗, 安全用药, 免疫治疗, 化疗方案, 不良反应, 用药指导","本篇文章深入解析FOLFOX化疗和信迪利单抗的用法、机制与不良反应，为胃癌患者提供安全合理的用药指导，帮助他们有效应对治疗挑战。","2025-07-16 22:34:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]